ASTRAZEN
Invest with MTF
Invest Now
Invest in AstraZeneca Pharma India with 3.23X leverage
Performance
- Low
- ₹8,254
- High
- ₹8,360
- 52 Week Low
- ₹6,620
- 52 Week High
- ₹10,691
- Open Price₹8,336
- Previous Close₹8,347
- Volume5,165
- 50 DMA₹8,742.59
- 100 DMA₹8,844.28
- 200 DMA₹8,644.27
Investment Returns
- Over 1 Month -9.26%
- Over 3 Month -10.57%
- Over 6 Month -7.82%
- Over 1 Year + 20.07%
Smart Investing Starts Here Start SIP with AstraZeneca Pharma India for Steady Growth!
AstraZeneca Pharma India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 104.4
- PEG Ratio
- 0.7
- Market Cap Cr
- 20,798
- P/B Ratio
- 26
- Average True Range
- 200.68
- EPS
- 92.47
- Dividend Yield
- 0.4
- MACD Signal
- -195.41
- RSI
- 36.47
- MFI
- 17.8
AstraZeneca Pharma India Financials
AstraZeneca Pharma India Technicals
EMA & SMA
Current Price
₹8,319.00
-28
(-0.34%)
- Bearish Moving Average 13
- Bullish Moving Average 3
- 20 Day
- ₹8,477.46
- 50 Day
- ₹8,742.59
- 100 Day
- ₹8,844.28
- 200 Day
- ₹8,644.27
Resistance and Support
8311
- R3 8,474.00
- R2 8,417.00
- R1 8,368.00
- S1 8,262.00
- S2 8,205.00
- S3 8,156.00
AstraZeneca Pharma India Corporate Actions - Bonus, Splits, Dividends
AstraZeneca Pharma India F&O
About AstraZeneca Pharma India
- NSE Symbol
- ASTRAZEN
- BSE Symbol
- 506820
- Managing Director
- Mr. Praveen Rao Akkinepally
- ISIN
- INE203A01020
Similar Stocks to AstraZeneca Pharma India
AstraZeneca Pharma India FAQs
AstraZeneca Pharma India share price is ₹8,319 As on 26 January, 2026 | 00:52
The Market Cap of AstraZeneca Pharma India is ₹20797.5 Cr As on 26 January, 2026 | 00:52
The P/E ratio of AstraZeneca Pharma India is 104.4 As on 26 January, 2026 | 00:52
The PB ratio of AstraZeneca Pharma India is 26 As on 26 January, 2026 | 00:52
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.